compound introduction
LTI-291是第一个用于治疗帕金森病的Glucocerebrosidase(GCase)小分子激活剂。 是葡糖脑苷脂酶 (Gcase) 的激活剂 Information LTI-291 is the first small-molecule activator ofGlucocerebrosidase(GCase)for the treatment of parkinson's disease.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
LTI-291
CAS number：1919820-28-2 molecular formula：C20H30N4O2
overview
Specs
| Chinese alias | - | ||
| English alias | 5,7-Dimethyl-N-(4-pentoxycyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide | LTI291 | LTI-291 | HY-104038 | EX-A2518 | UNII-V9WUN9UUU8 | D70023 | LTI 291 | 1919820-28-2 | SCHEMBL19024862 | BCP25413 | AC-36113 | SCHEMBL17739965 | V9WUN9UUU8 | 5,7-dimethyl | ||
| CAS number | 1919820-28-2 | molecular formula | C20H30N4O2 |
| molecular weight | 358.48 g/mol | Exact mass | 10mM in DMSO |
| PSA | 68.500 Ų | logp | 3.400 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
